Total tumor RNA transfected autologous dendritic cell vaccine (Duke University)
总肿瘤RNA转染自体树突细胞疫苗（杜克大学）
Report date: 2022/07/04 19:38:02
Base Information
Drug NameTotal tumor RNA transfected autologous dendritic cell vaccine (Duke University)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of Florida
Inactive CompaniesDuke UniversityNational Center For Research Resources
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A